Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed toward growing the horizons of cytokine-based immunotherapy, especially for cancers where remedy options remain limited. Utilize the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline https://financefeeds.com/atfx-appoints-paresh-patel-as-global-head-of-trading-risk-management/